MolNFT v1 · #7580 · protein
Towards structure-based drug design: crystal structure of a multisubstrate adduct complex of glycinamide ribonucleotide transformylase at 1.96 ångströms resolution
1GAR: “Towards structure-based drug design: crystal structure of a multisubstrate adduct complex of glycinamide…”. X-ray diffraction. MolNFT v1 #7580 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 1GAR
- Type
- protein
- Length
- 399 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P08179
Structure
x-ray diffraction · 2 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 205 | — | P08179 |
| B | — | protein | 194 | — | P08179 |
Compared structures
- 1GAR · Towards structure-based drug design: crystal structure of a multisubstrate adduct complex… · the same entry in another collection · chain A against A, TM-score 1.00
- P08179 · AlphaFold monomer V2.0 prediction for phosphoribosylglycinamide formyltransferase (P08179) · a predicted model of the same protein · chain B against A, TM-score 0.98
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P08179
- Elsewhere: RCSB PDB 1GAR · PDBe 1GAR · UniProt P08179
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.